US5981165A
(en)
*
|
1991-07-08 |
1999-11-09 |
Neurospheres Holdings Ltd. |
In vitro induction of dopaminergic cells
|
EP0721464A4
(de)
*
|
1993-09-01 |
1998-12-30 |
Start Technology Partnership |
Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen
|
WO1995017203A1
(en)
*
|
1993-12-22 |
1995-06-29 |
The University Of Medicine And Dentistry Of New Jersey |
Novel nucleic acid sequences isolated from glial cells
|
US5534615A
(en)
*
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
US6472585B1
(en)
|
1994-04-25 |
2002-10-29 |
Genentech, Inc. |
Cardiotrophin-1 defective mouse
|
DK0755446T3
(da)
*
|
1994-04-25 |
2007-01-29 |
Genentech Inc |
Cardiotrophin og anvendelser deraf
|
US7258983B2
(en)
|
1994-04-25 |
2007-08-21 |
Genentech, Inc. |
Cardiotrophin-1 compositions and methods for the treatment of tumor
|
US5853385A
(en)
*
|
1994-08-26 |
1998-12-29 |
Cytotherapeutics, Inc. |
Encapsulated PC12 cell transplants for treatment of Parkinson's disease
|
US5733875A
(en)
*
|
1994-11-15 |
1998-03-31 |
Amgen Inc. |
Methods of using GDNF as a neuroprotective agent
|
JP3093974B2
(ja)
*
|
1995-06-27 |
2000-10-03 |
住友ベークライト株式会社 |
神経細胞用培養液、その製造方法及びこれを用いる神経細胞の培養方法
|
US5739307A
(en)
*
|
1995-08-28 |
1998-04-14 |
Washington University |
Polynucleotide encoding neurturin neurotrophic factor
|
US6743628B1
(en)
|
1995-08-28 |
2004-06-01 |
Washington University |
Method of cell culture using neurturin
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
US6184200B1
(en)
|
1995-09-28 |
2001-02-06 |
Amgen Inc. |
Truncated glial cell line-derived neurotrophic factor
|
US5641749A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
WO1997019693A1
(en)
*
|
1995-11-29 |
1997-06-05 |
Amgen Inc. |
Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product
|
US5641750A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5905027A
(en)
*
|
1995-12-27 |
1999-05-18 |
Uab Research Foundation |
Method of diagnosing and treating gliomas
|
US5837681A
(en)
*
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5929041A
(en)
*
|
1996-02-23 |
1999-07-27 |
Amgen Inc. |
Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
|
CA2246768C
(en)
|
1996-03-14 |
2013-12-31 |
Genentech, Inc. |
Uses of gdnf and gdnf receptor
|
NZ329482A
(en)
*
|
1996-03-14 |
2000-05-26 |
Univ Washington |
A growth factor persephin related to the GDNF/neurturin family of growth factors Methods of treating conditions related to persephin deficiency detecting gene alterations and identifying other members of the family are included
|
US7015316B1
(en)
|
1996-03-14 |
2006-03-21 |
Washington University |
Polynucleotides encoding human persephin and related growth factors
|
US6222022B1
(en)
*
|
1996-03-14 |
2001-04-24 |
Washington University |
Persephin and related growth factors
|
US5741778A
(en)
*
|
1996-03-19 |
1998-04-21 |
Amgen Inc. |
Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US6455277B1
(en)
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
WO1997039629A1
(en)
*
|
1996-04-25 |
1997-10-30 |
Genetic Therapy, Inc. |
Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor
|
WO1998004688A1
(en)
*
|
1996-07-29 |
1998-02-05 |
Biopharm Gmbh |
Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons
|
JP2001512306A
(ja)
*
|
1997-01-08 |
2001-08-21 |
ライフ テクノロジーズ,インコーポレイテッド |
タンパク質の産生方法
|
US6372453B1
(en)
|
1997-02-18 |
2002-04-16 |
Genetech, Inc. |
Neurturin receptor
|
US6025157A
(en)
*
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
US6042579A
(en)
*
|
1997-04-30 |
2000-03-28 |
Medtronic, Inc. |
Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
|
SI1005358T1
(en)
*
|
1997-07-30 |
2003-06-30 |
Amgen Inc. |
Use of a neurturin protein product for preventing and treating hearing loss
|
US6043221A
(en)
*
|
1997-07-30 |
2000-03-28 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neuturin protein product
|
ATE360066T1
(de)
*
|
1997-08-05 |
2007-05-15 |
Hoffmann La Roche |
Aus einer menschlichen glial zelllinie- abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit
|
AU765070B2
(en)
|
1998-03-23 |
2003-09-11 |
Genentech Inc. |
GFRalpha3 and its uses
|
US7026138B1
(en)
|
1998-03-23 |
2006-04-11 |
Genentech, Inc. |
Polynucleotides encoding GFRα3
|
DE19816186A1
(de)
*
|
1998-04-14 |
1999-10-21 |
Univ Muenchen L Maximilians |
GDNF-kodierende DNA, Teile davon und GDNF-Varianten
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
US20020002269A1
(en)
*
|
1998-09-29 |
2002-01-03 |
Jeffrey D. Milbrandt |
Artemin, a neurotrophic factor
|
US7060676B2
(en)
*
|
1999-12-20 |
2006-06-13 |
Trustees Of Tufts College |
T. cruzi-derived neurotrophic agents and methods of use therefor
|
US20040014082A1
(en)
*
|
2000-08-11 |
2004-01-22 |
Invitrogen Corporation |
Highly homogeneous molecular markers for electrophoresis
|
US6426065B1
(en)
*
|
2000-11-07 |
2002-07-30 |
Clairol Incorporated |
Use of tris(hydroxymethyl)aminomethane in cold permanent waving processes
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
ES2374971T3
(es)
|
2001-03-28 |
2012-02-23 |
Biogen Idec Ma Inc. |
Uso de polipéptidos de neublastina para el tratamiento del dolor neuropático.
|
US20030050273A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Keiya Ozawa |
Compositions and methods for treating neurodegenerative diseases
|
US7613491B2
(en)
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8364229B2
(en)
*
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US7828728B2
(en)
*
|
2003-07-25 |
2010-11-09 |
Dexcom, Inc. |
Analyte sensor
|
WO2003090689A2
(en)
*
|
2002-04-25 |
2003-11-06 |
Wisconsin Alumni Research Foundation |
Neurodegenerative disorder treatment using gdnf secreting neural cells
|
US20060088899A1
(en)
*
|
2002-05-31 |
2006-04-27 |
Alvarez Vernon L |
Combination chemotherapy with chlorotoxin
|
WO2007068784A1
(en)
|
2005-12-14 |
2007-06-21 |
Licentia Ltd |
Novel neurotrophic factor protein and uses thereof
|
US7528112B2
(en)
|
2002-11-15 |
2009-05-05 |
Drexel University |
Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
|
US20060018882A1
(en)
*
|
2004-06-21 |
2006-01-26 |
Kaemmerer William F |
Medical devices and methods for delivering compositions to cells
|
US7388079B2
(en)
*
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
KR20060002745A
(ko)
*
|
2003-01-13 |
2006-01-09 |
마헨드라 에스 라오 |
치료적 생성물의 전달을 위한 증식성 줄기세포 및전구세포에서의 후보 분자의 지속적 발현
|
US20040209810A1
(en)
*
|
2003-02-24 |
2004-10-21 |
Gill Steven S. |
Method of treating Parkinson's disease in humans by intraputaminal infusion of glial cell-line derived neurotrophic factor
|
US8946151B2
(en)
|
2003-02-24 |
2015-02-03 |
Northern Bristol N.H.S. Trust Frenchay Hospital |
Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen
|
EP1618179B1
(de)
|
2003-04-18 |
2014-05-07 |
Biogen Idec MA Inc. |
Polymerkonjugiertes glycosyliertes neublastin
|
US7875293B2
(en)
*
|
2003-05-21 |
2011-01-25 |
Dexcom, Inc. |
Biointerface membranes incorporating bioactive agents
|
DE602004028769D1
(de)
|
2003-06-10 |
2010-09-30 |
Nsgene As |
Verbesserte Sekretion von Neublastin
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
EP1648298A4
(de)
|
2003-07-25 |
2010-01-13 |
Dexcom Inc |
Sauerstoffverbessernde membransysteme für implantierbare vorrichtungen
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9135402B2
(en)
|
2007-12-17 |
2015-09-15 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US20050049196A1
(en)
*
|
2003-08-29 |
2005-03-03 |
Michael Hutchinson |
Indirect delivery of growth factors into the central nervous system
|
WO2005023861A2
(en)
*
|
2003-09-05 |
2005-03-17 |
Licentia, Ltd. |
Gdnf-related neuropeptides
|
US7598059B2
(en)
|
2003-10-02 |
2009-10-06 |
Biogen Idec Ma Inc. |
Neublastin expression constructs
|
CN1897977A
(zh)
*
|
2003-10-20 |
2007-01-17 |
Ns基因公司 |
帕金森氏病的体内基因治疗
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
US8093205B2
(en)
*
|
2003-12-01 |
2012-01-10 |
Medtronic, Inc. |
Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis
|
US20050123526A1
(en)
*
|
2003-12-01 |
2005-06-09 |
Medtronic Inc. |
Administration of growth factors for neurogenesis and gliagenesis
|
US7364592B2
(en)
*
|
2004-02-12 |
2008-04-29 |
Dexcom, Inc. |
Biointerface membrane with macro-and micro-architecture
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
GB2414934A
(en)
*
|
2004-06-11 |
2005-12-14 |
Gill Steven Streatfield |
Treatment of Parkinson's disease with GDNF
|
US8989833B2
(en)
|
2004-07-13 |
2015-03-24 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
CN101123978B
(zh)
|
2004-08-19 |
2012-12-12 |
比奥根艾迪克Ma公司 |
神经胚素变体
|
MX2007002029A
(es)
|
2004-08-19 |
2007-03-28 |
Biogen Idec Inc |
Variantes de neublastina.
|
US8133178B2
(en)
|
2006-02-22 |
2012-03-13 |
Dexcom, Inc. |
Analyte sensor
|
EP1919933A2
(de)
*
|
2005-08-16 |
2008-05-14 |
Copenhagen University |
Von gdnf abgeleitete peptide
|
US8142781B2
(en)
*
|
2005-10-07 |
2012-03-27 |
Armagen Technologies, Inc. |
Fusion proteins for blood-brain barrier delivery
|
US8741260B2
(en)
*
|
2005-10-07 |
2014-06-03 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of GDNF to the CNS
|
US8124095B2
(en)
*
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
CA2627543A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Ns Gene A/S |
Implantable biocompatible immttnoisolatory vehicle for delivery of gdnf
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
EP2019683B2
(de)
|
2006-04-25 |
2022-08-03 |
The Regents of The University of California |
Verabreichung von wachstumsfaktoren zur behandlung von zns-erkrankungen
|
WO2007127839A2
(en)
*
|
2006-04-26 |
2007-11-08 |
The Regents Of The University Of California |
Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
|
EP1872790A1
(de)
|
2006-06-26 |
2008-01-02 |
DeveloGen Aktiengesellschaft |
Neue Zusammensetzung zur Erhöhung der Bioverfügbarkeit von Neurturin
|
CA2661042C
(en)
*
|
2006-08-18 |
2012-12-11 |
Armagen Technologies, Inc. |
Agents for blood-brain barrier delivery
|
KR100770440B1
(ko)
*
|
2006-08-29 |
2007-10-26 |
삼성전기주식회사 |
질화물 반도체 발광소자
|
US8637459B2
(en)
|
2006-11-08 |
2014-01-28 |
Emory University |
Enhancing a population of insulin releasing cells using GFR-A1 agonists
|
JP5583005B2
(ja)
|
2007-05-01 |
2014-09-03 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
血管新生を増大させるための組成物および方法
|
WO2008137066A1
(en)
*
|
2007-05-02 |
2008-11-13 |
The Board Of Regents Of The University Of Oklahoma |
Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
|
US20200037874A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
EP2167071B1
(de)
*
|
2007-06-13 |
2020-03-18 |
Wayne State University Board Of Governors |
Baclofen-lösung zur niedrigvolumigen therapeutischen abgabe
|
CA2721135A1
(en)
*
|
2007-06-13 |
2008-12-24 |
Wayne State University Board Of Governors |
A zwitterion solution for low-volume therapeutic delivery
|
EP2182980A4
(de)
|
2007-07-27 |
2012-04-18 |
Armagen Technologies Inc |
Verfahren und zusammensetzungen für erhöhte alpha-iduronidase-aktivität im zns
|
EP2227132B1
(de)
|
2007-10-09 |
2023-03-08 |
DexCom, Inc. |
Integriertes insulin-abgabesystem mit kontinuierlichem glucosesensor
|
FI20070808A0
(fi)
|
2007-10-25 |
2007-10-25 |
Mart Saarma |
GDNF:n silmukointivariantit ja niiden käytöt
|
US8417312B2
(en)
|
2007-10-25 |
2013-04-09 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US8290559B2
(en)
|
2007-12-17 |
2012-10-16 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
US20090247855A1
(en)
|
2008-03-28 |
2009-10-01 |
Dexcom, Inc. |
Polymer membranes for continuous analyte sensors
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
US8227439B2
(en)
|
2008-05-15 |
2012-07-24 |
Morphotek, Inc. |
Treatment of metastatic tumors
|
JP6066035B2
(ja)
|
2009-02-12 |
2017-01-25 |
クルナ・インコーポレーテッド |
グリア細胞由来神経栄養因子(gdnf)関連疾病の、gdnfに対する天然アンチセンス転写物の抑制による治療
|
JP5873003B2
(ja)
|
2009-03-18 |
2016-03-01 |
アーメイゲン・テクノロジーズ・インコーポレイテッドArmagen Technologies, Inc. |
IgGデコイ受容体融合タンパク質の血液脳関門送達のための組成物および方法
|
US20110002897A1
(en)
|
2009-06-11 |
2011-01-06 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
EP3533467B1
(de)
*
|
2009-10-09 |
2023-07-26 |
Armagen, Inc. |
Verfahren und zusammensetzungen zur erhöhung der iduronat-2-sulfatase-aktivität im zns
|
WO2011064437A2
(es)
|
2009-11-26 |
2011-06-03 |
Proyecto De Biomedicina Cima, S.L. |
Vectores virales y procedimientos útiles en la preparación de gdnf
|
PT2531206T
(pt)
|
2010-02-04 |
2017-09-05 |
Morphotek Inc |
Polipéptidos clorotoxina e conjugados e usos dos mesmos
|
CN106957356B
(zh)
|
2010-05-11 |
2021-05-25 |
弗雷德哈钦森癌症研究中心 |
氯毒素变体、缀合物及其使用方法
|
CN103502464B
(zh)
|
2010-12-02 |
2016-03-23 |
神经技术美国有限公司 |
分泌抗血管生成抗体支架和可溶性受体的细胞系及其用途
|
UA112981C2
(uk)
|
2011-04-11 |
2016-11-25 |
Елі Ліллі Енд Компані |
Варіант людського gdnf
|
EP4218570A3
(de)
|
2011-08-26 |
2023-10-04 |
DexCom, Inc. |
Polymermembranen für kontinuierliche analytsensoren
|
EP2785378B1
(de)
|
2011-12-02 |
2020-05-13 |
Armagen, Inc. |
Verfahren und zusammensetzungen für erhöhte sulfatase-a-aktivität im zns
|
US9788765B2
(en)
|
2012-09-28 |
2017-10-17 |
Dexcom, Inc. |
Zwitterion surface modifications for continuous sensors
|
SG11201504602VA
(en)
|
2012-12-10 |
2015-07-30 |
Hutchinson Fred Cancer Res |
Lipocalin fusion partners
|
WO2014152511A1
(en)
|
2013-03-15 |
2014-09-25 |
The Jackson Laboratory |
Methods for promoting wound healing and hair growth
|
US9737250B2
(en)
|
2013-03-15 |
2017-08-22 |
Dexcom, Inc. |
Membrane for continuous analyte sensors
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
US10369329B2
(en)
|
2014-01-30 |
2019-08-06 |
Renishaw Plc |
Neurosurgical apparatus and method
|
EP3140429B1
(de)
|
2014-05-05 |
2020-02-19 |
Medtronic Inc. |
Verfahren zur scd-, crt-, crt-d- oder sca-therapieidentifizierung und/oder auswahl
|
US10538589B2
(en)
|
2015-01-14 |
2020-01-21 |
Armagen Inc. |
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
|
GB201506052D0
(en)
|
2015-04-09 |
2015-05-27 |
Renishaw Plc |
Movement disorder
|
CA2986769A1
(en)
|
2015-05-27 |
2016-12-01 |
Neurotech Usa, Inc. |
Use of encapsulated cell therapy for treatment of ophthalmic disorders
|
EP4324921A3
(de)
|
2015-12-30 |
2024-05-01 |
Dexcom, Inc. |
Biogrenzflächenschicht für analytsensoren
|
US12048732B2
(en)
|
2016-04-15 |
2024-07-30 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
US11912750B2
(en)
|
2016-11-10 |
2024-02-27 |
Keros Therapeutics, Inc. |
GDNF fusion polypeptides and methods of use thereof
|
US20220296867A1
(en)
|
2021-03-19 |
2022-09-22 |
Dexcom, Inc. |
Drug releasing membrane for analyte sensor
|
CA3230350A1
(en)
|
2021-09-15 |
2023-03-23 |
Shanger Wang |
Bioactive releasing membrane for analyte sensor
|
AU2022397707A1
(en)
|
2021-11-29 |
2024-06-13 |
Shanghai Regenelead Therapies Co., Ltd. |
Aadc/gdnf polynucleotide, and use thereof in treating parkinson's disease
|
WO2023150646A1
(en)
|
2022-02-02 |
2023-08-10 |
Dexcom, Inc. |
Sensing systems and methods for diagnosing, staging, treating, and assessing risks of liver disease using monitored analyte data
|
WO2023164584A1
(en)
|
2022-02-23 |
2023-08-31 |
Dexcom, Inc. |
Sensing systems and methods for providing decision support around kidney health and/or diabetes
|
US20230389844A1
(en)
|
2022-06-01 |
2023-12-07 |
Dexcom, Inc. |
Sensing systems and methods for diagnosing kidney disease
|
US20240090802A1
(en)
|
2022-09-02 |
2024-03-21 |
Dexcom, Inc. |
Continuous analyte sensor devices and methods
|
US20240225490A1
(en)
|
2022-12-30 |
2024-07-11 |
Dexcom, Inc. |
Sensing systems and methods for hybrid glucose and ketone monitoring
|